Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about European projects that are funded by European programmes including FP7, H2020, IMI, JNPD, AAL and EU Health. For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Design and Integration of Graphene Fibre Based Antennas for Smart Textiles

GFSMART

Smart textiles that provide a seamless command-oriented user interface and have capable of wireless communication, have become active research field in recent decades with interest of wearable and attractive platforms. Well-known mechanical requirements such as light weight, compactness, and flexibility, that smart components should be invisibly...

Funding Programme
Start Date
End Date
Total Funding
€ 195 455
European Countries Involved

Designing for People with Dementia: designing for mindful self-empowerment and social engagement

MinD

This project aims to help people with dementia engage in social contexts to improve psychosocial wellbeing. People who are affected by Alzheimer’s disease or other dementias often face cognitive, behavioural and psychosocial difficulties, including impairment and degeneration of memory and of perceptions of identity. In a social context, this can...

Funding Programme
Start Date
End Date
Total Funding
€ 549 000
European Countries Involved

Designing the I-Do Service: Facilitating Inclusion and Empowerment of People Living with Dementia through Access to Cultural and Creative Activities

IDoService

This fellowship will co-develop, implement and evaluate the I-Do service to increase the socio-cultural participation and empowerment of people living with mild to moderate stages of dementia (PLWD) through an interdisciplinary engaged research approach that combines service design and psychology with a co-design methodology. This user-friendly...

Funding Programme
Start Date
End Date
Total Funding
€ 212 934
European Countries Involved

Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging

DiSCo MRI SFN

MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic burden continue to rise. Structural and functional MRI can provide biomarkers for early diagnosis and potential therapeutic intervention. My research vision is to develop novel MRI methods for structural and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 721 726
European Countries Involved

Developing new therapies for Batten disease

BATCure

The goal of BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases - neuronal ceroid lipofuscinoses (NCL) or Batten disease. There are > thousand affected across Europe, with a combined incidence of c.1:100 000. The NCLs are devastating and debilitating genetic disorders that mainly affect children...

Funding Programme
Start Date
End Date
Total Funding
€ 6 000 681
European Countries Involved

Development and application of global lipidomic arrays to inflammatory vascular disease

LIPIDARRAY

How lipids are regulated on a global scale during vascular inflammation is not known. Thus, a major challenge exists to describe and catalog the total lipidome, in particular enabling the identification of new biologically active lipids, and description of changes. This is analogous to ‘omics’ of DNA, RNA and protein, but instead describing...

Funding Programme
Start Date
End Date
Total Funding
€ 2 969 345
European Countries Involved

Development of a late-onset-Alzheimer’s disease (LOAD) profile for accurate diagnosis and identification of potential therapeutic approaches

LOAD PROFILE

Late-onset Alzheimer’s disease (LOAD) is a neurodegenerative disorder that currently affects 2% of the population in industrialized countries; the risk of LOAD increases in individuals beyond the age of 70 and it is predicted that the incidence of LOAD will increase 4-fold within the next 50 years which may cause a great socioeconomic problem...

Funding Programme
Start Date
End Date
Total Funding
€ 747 300
European Countries Involved

Development of a multiplex nanofluidic assay for selective detection and monitoring of Alzheimer's disease biomarkers

NANOASSAY

In this work, I propose the use of a nano/microfluidic system to detect biomarkers relevant to Alzheimer’s disease (AD). The use of this system could give earlier and more accurate diagnoses, as well as provide the opportunity for therapeutic interventions and effective disease monitoring. Prior to the diagnosis of dementia and even before the...

Funding Programme
Start Date
End Date
Total Funding
€ 168 794
European Countries Involved

Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders

NEUROFGL

Neurodegenerative disorders such as, Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), stroke, Traumatic Brain Injury (TBI) and chronic stress create a major economic burden to society and a substantial reduction in quality of life for patients and families. The development of neuroregenerative therapies is notoriously difficult and...

Funding Programme
Start Date
End Date
Total Funding
€ 7 807 910
European Countries Involved

Development of a Novel Multicellular In Vitro Model of Alzheimer’s disease-like Blood-Brain Barrier

NAB3

A striking challenge in diagnosis and therapy of neurodegenerative diseases is the design of drugs capable of crossing the blood-brain barrier (BBB), a tightly regulated barrier that prevents the passage of drugs from the blood to the brain. In vitro cellular BBB models are available, but they mimic only healthy conditions without taking into...

Funding Programme
Start Date
End Date
Total Funding
€ 812 488
European Countries Involved

Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease

D3i4AD

Alzheimer’s disease (AD) is the major cause of dementia which has no cure at the moment. The overall aim of the work described in this proposal is to create a long-term strategic partnership between Sheffield University (UK), Lisbon University (Portugal), Eli Lilly (UK) and Biofordrug (Italy) in order to develop chemical biology tools for better...

Funding Programme
Start Date
End Date
Total Funding
€ 2 208 898
European Countries Involved

Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia

DIPPA-FTD

The behavioural variant of frontotemporal dementia (bvFTD) is a common cause of early-onset dementia that presents with changes in behavior and personality. It is often misdiagnosed and mistaken for a psychiatric disorder, such as depression or bipolar disorder. Unlike with Alzheimer’s disease, we still lack reliable tests that enable a diagnosis...

Funding Programme
Start Date
End Date
Total Funding
€ 1 320 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).